top of page

News


Search


A breathe-easier breakthrough
Renovion, a UNC-affiliated startup, advances a breakthrough therapy to restore lung health and quality of life in patients with diseases...
Renovion
Nov 18, 20216 min read


Renovion and the COPD Foundation Launch COPD and Bronchiectasis Development Partnership
Renovion and the COPD Foundation have announced the creation of a new partnership to accelerate the development of a novel therapy for...
Renovion
Sep 21, 20213 min read


Publication of Research Demonstrating the Impact of ARINA-1 on Mucus Transport in Cystic Fibrosis
Renovion, Inc., a biopharmaceutical company on a mission to transform the lives of patients with chronic lung diseases characterized by...
Renovion
Jul 9, 20202 min read


Renovion Receives Orphan Designation for ARINA-1 for the treatment of Lung Dysfunction
Renovion, Inc. ("Renovion"), an early stage drug development company targeting the treatment of lung transplant and other chronic...
Renovion
Jan 6, 20172 min read

bottom of page